At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
Vagus Nerve Stimulation Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ASCEND: Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
In Brief
An observational study evaluating Vagus Nerve Stimulation Therapy for Epilepsy and Seizures. Completed, enrolled 67 participants across 15 sites.
Detailed Summary
Post-market, on-label, double-blind, randomized, prospective, interventional, tolerability and clinical outcomes study to determine the number of patients achieving their final assigned VNS Therapy dose settings in patients with drug-resistant epilepsy who are being treated with adjunctive VNS Therapy using new titration protocols.
Study Details
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartApr 2015
Primary CompletionOct 2016
TodayJul 2026
First PostedMar 11, 2015
Enrollment StartApr 28, 2015
Primary CompletionOct 10, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.3 years ago
Interventions
Vagus Nerve Stimulation Therapydevice
Stimulation of the left tenth cranial nerve via VNS Therapy